Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction

被引:34
作者
Vergel, C [1 ]
Walker, J [1 ]
Saravia, NG [1 ]
机构
[1] Ctr Int Entrenamiento & Invest Med, Cali, Valle, Colombia
关键词
D O I
10.4269/ajtmh.2005.72.423
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We evaluated the Leishmania Viannia-specific primers B1-B2 to detect Leishmania in normal skin and peripheral blood monocytes of patients with active cutaneous leishmaniasis. Southern blotting and sequencing of polymerase chain reaction (PCR) products confirmed the specificity of kinetoplast DNA (kDNA) amplification from tissue fluid from healthy skin, whereas the PCR with monocytes also amplified a human sequence of a size similar (7 18 basepairs) to the expected kDNA product (750 basepairs), resulting in false-positive results. Although 131 was not homologous to any human DNA sequence, B2 showed homology to a human chromosome 2 intergenic region (AC010878) at positions 35,881-36,599, which are spaced 718 nucleotides apart. Amplification of the human artifact from monocyte DNA was confirmed using the primer B2 alone. Examination of other primers reported for the PCR of kDNA from various species of Leishmania showed that six of seven were homologous to human DNA sequences. These findings underscore the importance of exploiting sequencing, bioinformatics, and DNA probes to refine molecular amplification techniques and to validate the performance of primers when used for new applications.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 18 条
[1]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[2]  
Ausubel F.M., 1994, CURRENT PROTOCOLS MO
[3]   Simplified polymerase chain reaction detection of New World Leishmania in clinical specimens of cutaneous leishmaniasis [J].
Belli, A ;
Rodriguez, B ;
Aviles, H ;
Harris, E .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (01) :102-109
[4]  
BRUJIN M, 1992, ACTA TROP, V52, P45
[5]   New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species [J].
Castilho, TM ;
Shaw, JJ ;
Floeter-Winter, LM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) :540-546
[6]   Worldwide increasing risk factors for leishmaniasis [J].
Desjeux, P .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2001, 190 (1-2) :77-79
[7]  
GALINDO I, 1993, APPL MICROBIOL BIOT, V39, P553, DOI 10.1007/BF00205050
[8]  
GOMESRODRIGUES EH, 2002, J CLIN MICROBIOL, V40, P3572
[9]   PRESENCE OF LEISHMANIA-BRAZILIENSIS IN BLOOD-SAMPLES FROM CURED PATIENTS OR AT DIFFERENT STAGES OF IMMUNOTHERAPY [J].
GUEVARA, P ;
ROJAS, E ;
GONZALEZ, N ;
SCORZA, JV ;
ANEZ, N ;
VALERA, M ;
RAMIREZ, JL .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (04) :385-389
[10]   Leishmaniasis [J].
Herwaldt, BL .
LANCET, 1999, 354 (9185) :1191-1199